194 related articles for article (PubMed ID: 9569908)
1. [Rhabdomyolysis in patients with preexisting myopathy, treated with antilipemic agents].
Franc S; Bruckert E; Giral P; Turpin G
Presse Med; 1997 Dec; 26(38):1855-8. PubMed ID: 9569908
[TBL] [Abstract][Full Text] [Related]
2. Myopathy and rhabdomyolysis with lipid-lowering drugs.
Hodel C
Toxicol Lett; 2002 Mar; 128(1-3):159-68. PubMed ID: 11869826
[TBL] [Abstract][Full Text] [Related]
3. [Fibrate and statine myopathy].
Finsterer J
Nervenarzt; 2003 Feb; 74(2):115-22. PubMed ID: 12596012
[TBL] [Abstract][Full Text] [Related]
4. DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus.
Pariente A; Labat V; Mansiaux Y; Salvo F; Bégaud B; Raschi E; Faillie JL; Létinier L; Bezin J
Drug Saf; 2020 Aug; 43(8):767-774. PubMed ID: 32306223
[TBL] [Abstract][Full Text] [Related]
5. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.
Pierce LR; Wysowski DK; Gross TP
JAMA; 1990 Jul; 264(1):71-5. PubMed ID: 2355431
[TBL] [Abstract][Full Text] [Related]
6. [Rhabdomyolysis secondary to simvastatin and phenofibrate].
Forcadell-Peris MJ; de Diego-Cabanes C
Semergen; 2014; 40(4):e91-4. PubMed ID: 24768027
[TBL] [Abstract][Full Text] [Related]
7. [Antilipemic therapy and rhabdomyolysis].
Paragh G; Balogh Z; Romics L
Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in 45 patients with statin-associated myopathy.
Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
[TBL] [Abstract][Full Text] [Related]
9. [Polymyositis induced or associated with lipid-lowering drugs: five cases].
Fauchais AL; Iba Ba J; Maurage P; Kyndt X; Bataille D; Hachulla E; Parent D; Queyrel V; Lambert M; Michon Pasturel U; Hatron PY; Vanhille P; Devulder B
Rev Med Interne; 2004 Apr; 25(4):294-8. PubMed ID: 15050796
[TBL] [Abstract][Full Text] [Related]
10. Statin-associated rhabdomyolysis with acute renal failure complicated by intradialytic NSTEMI: a review of lipid management considerations.
Kar S; Chockalingam A
Am J Ther; 2013 Jan; 20(1):57-60. PubMed ID: 21192242
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
Kamaliah MD; Sanjay LD
Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
[TBL] [Abstract][Full Text] [Related]
12. [Myopathies under therapy with lipid-lowering agents].
Köller H; Neuhaus O; Schroeter M; Hartung HP
Nervenarzt; 2005 Feb; 76(2):212-7. PubMed ID: 15609055
[TBL] [Abstract][Full Text] [Related]
13. [The combinations of statins and fibrates: pharmacokinetic and clinical implications].
González Santos P
Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():7-11. PubMed ID: 25043540
[TBL] [Abstract][Full Text] [Related]
14. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
Graham DJ; Staffa JA; Shatin D; Andrade SE; Schech SD; La Grenade L; Gurwitz JH; Chan KA; Goodman MJ; Platt R
JAMA; 2004 Dec; 292(21):2585-90. PubMed ID: 15572716
[TBL] [Abstract][Full Text] [Related]
15. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
16. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyolysis caused by Commiphora mukul, a natural lipid-lowering agent.
Bianchi A; Cantù P; Firenzuoli F; Mazzanti G; Menniti-Ippolito F; Raschetti R
Ann Pharmacother; 2004; 38(7-8):1222-5. PubMed ID: 15187214
[TBL] [Abstract][Full Text] [Related]
18. Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review.
Satarasinghe RL; Ramesh R; Riyaaz AA; Gunarathne PA; de Silva AP
Drug Metabol Drug Interact; 2007; 22(4):279-83. PubMed ID: 18447003
[TBL] [Abstract][Full Text] [Related]
19. Statins Neuromuscular Adverse Effects.
Attardo S; Musumeci O; Velardo D; Toscano A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955495
[TBL] [Abstract][Full Text] [Related]
20. Lipid-lowering drugs and risk of myopathy: a population-based follow-up study.
Gaist D; Rodríguez LA; Huerta C; Hallas J; Sindrup SH
Epidemiology; 2001 Sep; 12(5):565-9. PubMed ID: 11505177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
